Okamoto M, Sasano M, Goto M, Nishioka K, Aotsuka S, Nakamura K, Yokohari R
Institute of Rheumatology, Tokyo Women's Medical College, Japan.
Int J Immunopharmacol. 1991;13(1):39-43. doi: 10.1016/0192-0561(91)90023-z.
We developed an ELISA system for human IL-1 alpha and -beta release from silica-stimulated monocytes from healthy volunteers and tested the effect of several anti-rheumatic drugs including nonsteroidal anti-inflammatory drug (Ibuprofen). Anti-rheumatic drugs including Auranofin and Sulphasalazine suppressed IL-1 beta release significantly at therapeutic concentrations, whereas Bucillamine, Lobenzarit, D-Penicillamine and Ibuprofen did not. These results suggest a possible immunotherapeutic effectiveness of some anti-rheumatic drugs on rheumatoid arthritis through their inhibition of IL-1 beta release.